ISMPP Highlights
GPP4: Development Is Underway
ISMPP is honored to have the opportunity to sponsor the next iteration of the Good Publication Practice (GPP) guidelines, an industry-leading document to guide the ethical development of medical publications. Development of the GPP4 guidelines is now well underway, with a Steering Committee established and working steadily on revisions to the guidance…
Open Pharma Releases Position Statement on Open Access
Open Pharma recently released its Position Statement on Open Access, which advocates that access to pharmaceutical company-funded research should not be restricted by journal paywalls. The Position Statement points out that approximately half of all biomedical research is funded by pharmaceutical companies. In the Position Statement, Open Pharma sets out its…
It’s Not Who You Are, It’s What You Do: Determining Authorship for Industry-sponsored Publications
Challenges with authorship of industry-sponsored publications persist despite established guidelines and recommendations. While adherence to the ICMJE authorship recommendations is an accepted standard across the industry, there is considerable ambiguity in…
Message from Our Leadership
Robert J. Matheis
ISMPP President and CEO
News and Trends
What I Would Like You to Know: A Real-World Evidence Expert’s Perspective
What are one or two things you want your medical publication colleagues to know from your experience of working on real-world evidence (RWE) publications? First, research models and applications for RWE are quite different from clinical trials. Even the terminology involved is different…
Converting Insight to Action: Key Aspects of Competitive Intelligence for Strategic Planning
As medical affairs and medical publication professionals, it is important to understand how competitive intelligence can help inform our medical communication strategies and plans. However, many do not know where or how to obtain the needed information or…
Scientific Communication Platforms: Highlighting Current Best Practices
Scientific communication platforms (SCPs) were first introduced into pharmaceutical practices more than a decade ago. Since their introduction, SCPs have evolved to keep pace with the ever-changing needs of the healthcare landscape…
What Would You Do?
In our role as medical publication professionals, we may occasionally encounter situations in which it is not obvious how to ensure good publication practice. Have you ever wished you could consult the ISMPP membership for guidance when these situations arise? Here’s your opportunity!
What Would You Do? is a new section of The MAP that presents case scenarios as an educational tool for medical publication professionals. The section provides a case scenario to ponder, and readers are invited to participate in a poll by selecting one of the listed solutions. Readers can also submit their thoughts on the scenario anonymously. The poll results, plus educational insights, are posted in a later issue for readers to digest.
POLL RESULTS: Journal Editor Makes Substantial Changes on Page Proofs
You are a medical publication professional and have achieved acceptance of a manuscript into a top-tier journal after much discussion among authors and peer reviewers, resulting in several rewrites of the manuscript and its associated conclusions. You have now received page proofs for which comments need to be returned to the journal within 48 hours. The journal editor has made additional substantial changes…
ISMPP (pronounced IzMap) is the only nonprofit organization founded by medical publication professionals for medical publication professionals